Workflow
KOMZIFTI
icon
搜索文档
Kura Oncology Q1 Earnings Call Highlights
MarketBeat· 2026-05-13 09:10
Kura Oncology NASDAQ: KURA reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is showing early signs of physician uptake, broad payer coverage and use in combination regimens, according to management’s earnings call for the first quarter of 2026.President and Chief Executive Officer Dr. Troy Wilson described the company as being “at an inflection point,” citing the commercial launch, phase III programs that he said are ahead of plan an ...
Kura Oncology(KURA) - 2026 Q1 - Earnings Call Transcript
2026-05-13 05:32
Kura Oncology (NasdaqGS:KURA) Q1 2026 Earnings call May 12, 2026 04:30 PM ET Conference Call Participants Dan Bronder - Analyst Daniel Brims - Analyst David Dai - Analyst Etzer Darout - Analyst Jonathan Chang - Analyst Nabil Belhadj - Analyst Peter Green - Analyst Philip Nadeau - Analyst Reni Benjamin - Analyst Salim Syed - Analyst Operator Good day, everyone. My name is Layla, and I will be your conference operator today. At this time, I would like to welcome you to the Kura Oncology First Quarter 2026 fin ...
Kura Oncology(KURA) - 2026 Q1 - Earnings Call Transcript
2026-05-13 05:32
Kura Oncology (NasdaqGS:KURA) Q1 2026 Earnings call May 12, 2026 04:30 PM ET Company Participants Brian Powl - Chief Commercial Officer Greg Mann - SVP of Investor Relations and Corporate Affairs Mollie Leoni - Chief Medical Officer Tom Doyle - SVP of Finance and Accounting Troy Wilson - President and CEO Conference Call Participants Dan Bronder - Analyst Daniel Brims - Analyst David Dai - Analyst Etzer Darout - Analyst Jonathan Chang - Analyst Nabil Belhadj - Analyst Peter Green - Analyst Philip Nadeau - A ...
Kura Oncology(KURA) - 2026 Q1 - Earnings Call Transcript
2026-05-13 05:30
Kura Oncology (NasdaqGS:KURA) Q1 2026 Earnings call May 12, 2026 04:30 PM ET Speaker9Good day, everyone. My name is Layla, and I will be your conference operator today. At this time, I would like to welcome you to the Kura Oncology First Quarter 2026 financial results earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, and if you have joined via the w ...